Skip to main content

Colgate-Palmolive Company (CL) Stock Analysis

Breakout setup

HoldVALUE-TRAP 1/5High Confidence

Consumer Defensive · Household & Personal Products

Earnings in 0 days (2026-05-01). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Hold if already holding. Not a fresh buy at $88.20, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5.

Colgate-Palmolive manufactures and markets oral, personal, and home care products plus pet nutrition under brands like Colgate, Palmolive, Hill's Science Diet and Hill's Prescription Diet, with products sold in 200+ countries. Oral care (44%), personal care (17%), home care... Read more

$88.20+6.6% A.UpsideScore 5.5/10#6 of 13 Household & Personal Products
Entry $81.33(R/R-minimum solve)Stop $77.73Target $86.73(resistance)A.R:R -0.3:1Setup A.R:R 1.5:1
Analyst target$95.37+8.1%19 analysts
$86.73our TP
$88.20price
$95.37mean
$79
$105

Hold if already holding. Not a fresh buy at $88.20, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Downgraded from BUY WAIT — price $87.83 has reached target $86.73. No upside to wait for. Score 5.5/10, high confidence.

Passes 4/6 gates (positive momentum, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: moderate.

Val5.0Qual7.5Grw3.9Mom6.6Sent6.3Ins3.8Peer5.2Tech3.2Risk6.95.5OVERALL

Thesis

Rewards
No bull case signals
Risks
Analyst target reached - limited upside remaining
Leverage penalty (D/E 23.4): -1.5

Key Metrics

P/E (TTM)32.5
P/E (Fwd)21.0
Mkt Cap$68.5B
EV/EBITDA15.6
Profit Mgn10.5%
ROE497.5%
Rev Growth5.8%
Beta0.33
Dividend2.48%
Rating analysts30

Quality Signals

Piotroski F7/9

Options Flow

P/C0.67bullish
IV33%normal
Max Pain$95+7.7% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMSuppliersingle-source suppliers
    10-K Item 1A: 'we purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers'

Material Events(8-K, last 90d)

  • 2026-04-09Item 5.02MEDIUM
    Jennifer Daniels (CLO since 2014) to retire in 2026. Betsy Fishbone (Deputy CLO) appointed CLO effective June 1, 2026. Daniels elected Vice Chair for orderly transition of CLO responsibilities to Fishbone.
    SEC filing →
  • 2026-03-12Item 5.02LOW
    Christopher S. Boerner (CEO and Board Chair of Bristol-Myers Squibb) elected to the Colgate-Palmolive Board effective March 15, 2026. Routine board appointment; no officer departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
1.0
Gap
4.0
52w Position
7.8

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.9
Low model confidence on this dimension (33%).
GatesA.R:R -0.3=NEGATIVEEARNINGS PROXIMITY 0d<=7dMomentum 6.6>=5.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
64 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $81.79Resistance $88.50

Price Targets

$78
$81
$87
A.Upside-1.7%
A.R:R-0.3:1
Setup A.R:R (at entry)1.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (-2.3% upside)
! Earnings in 0 days - binary event risk
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-01 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CL stock a buy right now?

Hold if already holding. Not a fresh buy at $88.20, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Downgraded from BUY WAIT — price $87.83 has reached target $86.73. No upside to wait for. Target $86.73 (-1.7%), stop $77.73 (−13.5%), A.R:R -0.3:1. Score 5.5/10, high confidence.

What is the CL stock price target?

Take-profit target: $86.73 (+6.6% upside). Target $86.73 (-1.7%), stop $77.73 (−13.5%), A.R:R -0.3:1. Stop-loss: $77.73.

What are the risks of investing in CL?

Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5.

Is CL overvalued or undervalued?

Colgate-Palmolive Company trades at a P/E of 32.5 (forward 21.0). TrendMatrix value score: 5.0/10. Verdict: Hold.

What do analysts say about CL?

30 analysts cover CL with a consensus score of 3.7/5. Average price target: $95.

What does Colgate-Palmolive Company do?Colgate-Palmolive manufactures and markets oral, personal, and home care products plus pet nutrition under brands like...

Colgate-Palmolive manufactures and markets oral, personal, and home care products plus pet nutrition under brands like Colgate, Palmolive, Hill's Science Diet and Hill's Prescription Diet, with products sold in 200+ countries. Oral care (44%), personal care (17%), home care (16%), and pet nutrition (23%) make up net sales; roughly two-thirds of net sales originate outside the US.

Related stocks: UL (Unilever PLC) · PG (Procter & Gamble Company (The)) · KMB (Kimberly-Clark Corporation) · CHD (Church & Dwight Company, Inc.) · EL (Estee Lauder Companies, Inc. (T)